Nilotinib hydrochloride monohydrate is the monohydrate monohydrochloride salt form of nilotinib, an orally bioavailable aminopyrimidine-derivative tyrosine kinase inhibitor. It is a pharmaceutical raw material used in the manufacturing of active pharmaceutical ingredients for cancer research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 923288-90-8
Nilotinib
pharmaceutical raw material
Iodixanol
pharmaceutical raw material
Simeprevir
pharmaceutical raw material
(7S-cis)-9-Acetyl-9-amino-7-[(2-deoxy-alpha-D-erythro-pentopyranosyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxy-5,12-naphthacenedione
pharmaceutical raw material
Ursodeoxycholylglycine sodium
pharmaceutical raw material
N-Nitrosonilotinib
pharmaceutical intermediate
4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide;hydrate;hydrochloride
YCBPQSYLYYBPDW-UHFFFAOYSA-N
CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.O.Cl